New Zealand has rapidly emerged as a sophisticated hub for biotechnology, particularly in the production and application of Monoclonal Antibodies (mAbs). Leveraging its world-class academic institutions and a robust agricultural science heritage, the NZ biotech sector has moved from primary production into high-value medical manufacturing.
In the heart of the South Pacific, New Zealand manufacturers benefit from a unique "clean-green" image that translates to high standards of biosecurity and purity in biological production. The local industrial landscape is characterized by a mix of agile startups and established research institutes like the Malaghan Institute of Medical Research and AgResearch, focusing heavily on immunotherapy and recombinant protein technologies.
Strict NZ regulations ensure the highest grade of biological safety and product consistency.
Strategically positioned to export specialized mAb-based diagnostic kits to the Asia-Pacific region.
Home to cutting-edge research in cancer immunotherapy and veterinary diagnostics.
Hangzhou Jeci Biochem Technology Co., Ltd. is strategically located in Hangzhou, Zhejiang Province. We are a powerhouse committed to the sales of active pharmaceutical ingredients (APIs), pharmaceutical intermediates, nutritional products, and food additives. Our core strengths lie in cooperative R&D, custom manufacturing, and global export services.
In China, our collaboration with new drug research institutes and multi-functional custom processing plants allows us to lead in technological transfer and product applications. For the New Zealand market, we act as a bridge, providing high-quality raw materials and finished diagnostic solutions that meet the rigorous standards of NZ's healthcare system.
The Monoclonal Antibody industry in New Zealand is currently witnessing a transition toward Personalized Medicine. With the New Zealand government's increasing investment in health technology, the demand for localized rapid diagnostic kits (using mAbs) has spiked. From Auckland's clinical labs to rural veterinary clinics, the application of mAbs is diverse:
Our Monoclonal Antibody production and pharmaceutical intermediates are widely utilized across various industrial facets in New Zealand and beyond:
We are able to assemble and produce larger quantities of intermediates and provide some advanced, convenient manufacturing capabilities, including batch processing and customization. For our main product intermediates, we maximize our advantages to meet strict deadlines and high-quality requirements of our New Zealand partners.
The manufacturing process of Monoclonal Antibodies involves the cloning of a unique white blood cell to produce identical antibodies. Our focus on Single-Use Bioreactors (as seen in our product lineup) allows for rapid turnover and zero cross-contamination, which is critical for the sterile environments demanded by the New Zealand Ministry of Health and international regulators like the FDA and EMA.
Furthermore, our diagnostic kits, ranging from Malaria to H. Pylori and Drug Abuse tests, utilize colloidal gold and immunochromatography technologies. These products are designed for high sensitivity and specificity, ensuring that whether they are used in a hospital in Wellington or a home in Christchurch, the results are reliable and fast.
Trusted by Clinics and Research Facilities Across New Zealand
As New Zealand continues to strengthen its trade ties with China and the rest of Asia, the export of high-tech biologicals like Monoclonal Antibodies is set to grow. Our company, Hangzhou Jeci Biochem Technology, is at the forefront of this expansion, offering registration, consulting, and sales channel services for overseas companies looking to enter the Chinese market, while simultaneously supplying New Zealand with top-tier API and diagnostic solutions.
We are dedicated to sustainable manufacturing practices that align with New Zealand's environmental values, ensuring that our production of recombinant proteins and antibodies is not only effective but also ethically produced.
SJ medical
